Hospital Acquired Disease Testing Market (Pneumonia, UTI, Blood Stream, Surgical Site, MRSA Infection, and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
This report covers the market analysis for various diagnostic tests performed to detect hospital associated infections, also called as nosocomial infections. Morbidity rate of nosocomial infections is increasing rapidly worldwide,thereby driving the hospital associated infection (HAI) diagnostic market towards remarkable growth. The stakeholders for this study include manufacturers and providers ofdiagnostic solutions for nosocomial infections.
The global hospital acquired disease testing market is categorized on the basis of infection types,i.e., urinary tract infection, surgical site infection, pneumonia,blood stream infection, MRSA infection and others. A detailed market analysis and forecast for these segments has been provided in this study, in terms of market revenue (USD million) for the period 2011 to 2019.The report also provides the compounded annual growth rate (CAGR %) for each infection type for the forecast period 2013 to 2019, while market size estimations have been made considering 2012 as the base year.
Browse Complete report with TOC : http://www.marketresearchreports.biz/analysis-details/hospital-acquired-disease-testing-market-pneumonia-uti-blood-stream-surgical-site-mrsa-infection-and-others-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
In terms of geographical distribution, the global hospital acquired disease testing market has been classified into four geographical areas, namely North America, Europe, Asia-Pacific and Rest of the World (RoW). The current and future market sizes (in terms of USD million) of the above regional markets have been provided in the report for the period 2011 to 2019 with their growth rate (%) for the period 2013 to 2019. The study further offers recommendations and highlights of the market, which would be useful for the current and future market players to sustain and grow in the global hospital acquired disease testing market.
The market overview section of the report demonstrates the market dynamics and market trends such as the drivers, restraints and opportunities that influence the current nature and future status of this field. Impact factors such as market attractiveness analysis and Porter’s five forces analysis have also been explained in the market overview section of the report, in order to give a thorough analysis of the overall competitive scenario in the global hospital acquired disease testing market.
This report concludes with the company profiles section which includes key information about the major players in this market. Some of the key players profiled in this report include Diatherix Laboratories Inc., Gen-Probe Inc., Qiagen GmbH, L Hoffman La Roche,Cepheid, Inc., Life Technologies Corporation, Meridian Biosciences, Cantel Medical Corporation, Nordion, Inc.and others.
To Download Sample Report Visit @ http://www.marketresearchreports.biz/sample/sample/185661
The global hospital acquired disease testing market is segmented as follows:
Hospital Acquired Disease TestingMarket, by Infection Type
• Pneumonia infection
• Urinary tract infection
• Blood stream associated infection
• Surgical site infection
• MRSA infection
• Others
Hospital Acquired Disease TestingMarket, by Geography
• North America
• Europe
• Asia-Pacific
• Rest of the World
Table of Content
Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 List of Abbreviations
Chapter 2 Executive Summary
Chapter 3 Market Overview
3.1 Overview – Current Market Scenario and Future Market Trends
3.1.1 Global Hospital Acquired Disease Testing Market Revenue, by Infection Type, 2011 – 2019 (USD Million)
3.2 Drivers
3.2.1 Establishment of Government Guidelines and Code of Prevention of HAIs
3.2.2 Increasing Prevalence of HAIs and Rise in the Number of Drug Resistant Pathogens
3.2.3 Expiration of Patents of Basic PCRs
3.3 Restraints
3.3.1 Lack of Budget and Skilled Labour in Developing Countries
3.3.2 Stringent Regulations and Guidance Framework
3.3.3 Lack of Controlling Authorities and Control Programmes in Less Developed Regions
3.4 Opportunities
3.4.1 Passing of the Patient Care and Affordable Care Act in the United States
3.4.2 Technological Developments in the Field of Molecular Diagnostics
3.5 Porter’s Five Force Analysis for the Global Hospital Acquired Disease Testing Market
3.5.1 Bargaining Power of Suppliers
3.5.2 Bargaining Power of Buyers
3.5.3 Threat of New Entrants
3.5.4 Threat of Substitutes
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis of Global Hospital Acquired Disease Testing Market, by Geography
Buy A copy Of This Report: http://www.marketresearchreports.biz/analysis/185661
Chapter 4 Global Hospital Acquired Disease Testing, by Infection Type
4.1 Overview – Current Market Scenario and Future Market Trends
4.1.1 Global Hospital Acquired Disease Testing Market, 2011 – 2019 (USD Million)
4.2 Urinary Tract Infection (UTI) Testing
4.2.1 Global Urinary Tract Infection Testing Market Revenue, 2011 – 2019 (USD Million)
4.3 Surgical Site Infection (SSI) Testing
4.3.1 Global Surgical Site Infection (SSI) Testing Market Revenue, 2011 - 2019 (USD Million)
4.4 Pneumonia Testing
4.4.1 Global Pneumonia Testing Market Revenue, 2011 - 2019 (USD Million)
4.5 Blood Stream Infection (BSI) Testing
4.5.1 Global Blood Stream Infection Testing Market Revenue, 2011 - 2019 (USD Million)
4.6 Methicillin-resistant Staphylococcus Aureus (MRSA) Testing
4.6.1 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Market Revenue, 2011 - 2019 (USD Million)
4.7 Others (GI, Bone, Respiratory, Cardiovascular, Etc.)
4.7.1 Global Other (GI, Joints, Respiratory, Cardiovascular, Etc.) Infections Testing Market Revenue, 2011 - 2019 (USD Million)
4.7.2 Respiratory Infections
4.7.3 Bone Infections
4.7.4 Cardiovascular Infections
4.7.5 Gastrointestinal Infections
Chapter 5 Global Hospital Acquired Disease Testing, by Geography
5.1 Overview – Current Market Scenario and Future Market Trends
5.1.1 Global Hospital Acquired Disease Testing Market Revenue, by Geography, 2011-2019 (USD Million)
5.2 North America
5.2.1 North America Hospital Acquired Disease Testing Market Revenue, 2011 - 2019 (USD Million)
5.2.2 North America Hospital Acquired Disease Testing Market Revenue, by Infection Type, 2011 – 2019 (USD Million)
5.3 Europe
5.3.1 Europe Hospital Acquired Disease Testing Market Revenue, 2011 – 2019 (USD Million)
5.3.2 Europe Hospital Acquired Disease Testing Market Revenue, by Infection Type, 2011 – 2019 (USD Million)
5.4 Asia-Pacific
5.4.1 Asia-Pacific Hospital Acquired Disease Testing Market Revenue, 2011 – 2019 (USD Million)
5.4.2 Asia-Pacific Hospital Acquired Disease Testing Market Revenue, by Infection Type, 2011 – 2019 (USD Million)
5.5 Rest of the World (RoW)
5.5.1 Rest of the World (RoW) Hospital Acquired Disease Testing Market Revenue, 2011 – 2019 (USD Million)
5.5.2 RoW Hospital Acquired Disease Testing Market Revenue, by Infection Type, 2011 – 2019 (USD Million)
Chapter 6 Recommendations
6.1 Educating and Training Hospital Staff
6.2 Focus on Expansion in Emerging Economies
6.3 Regulatory Compliance
6.4 Adapt to the Needs of Different Consumer Types
Chapter 7 Company Profiles
7.1 Abbott Laboratories, Inc.
7.1.1 Company Overview
7.1.2 Financial Overview
7.1.3 Business Strategies
7.1.4 Recent Developments
7.2 Alere, Inc.
7.2.1 Company Overview
7.2.2 Financial Overview
7.2.3 Business Strategies
7.2.4 Recent Developments
7.3 Becton, Dickinson and Company
7.3.1 Company Overview
7.3.2 Financial Overview
7.3.3 Business Strategies
7.3.4 Recent Developments
7.4 bioMerieux, Inc.
7.4.1 Company Overview
7.4.2 Financial Overview
7.4.3 Business Strategies
7.4.4 Recent Developments
7.5 Cantel Medical Corporation
7.5.1 Company Overview
7.5.2 Financial Overview
7.5.3 Business Strategies
7.5.4 Recent Developments
7.6 Cepheid, Inc.
7.6.1 Company Overview
7.6.2 Financial Overview
7.6.3 Business Strategies
7.7 Diatherix Laboratories Inc.
7.7.1 Company Overview
7.7.2 Business Strategies
7.7.3 Recent Developments
7.8 Gen-Probe, Inc.
7.8.1 Company Overview
7.8.2 Financial Overview
7.8.3 Business Strategies
7.8.4 Recent Developments
7.9 F. Hoffman-La Roche, Ltd.
7.9.1 Company Overview
7.9.2 Financial Overview
7.9.3 Business Strategies
7.9.4 Recent Developments
7.10 Life Technologies Corporation
7.10.1 Company Overview
7.10.2 Financial Overview
7.10.3 Business Strategies
7.10.4 Recent Developments
7.11 Meridian Bioscience, Inc.
7.11.1 Company Overview
7.11.2 Financial Overview
7.11.3 Business Strategies
7.11.4 Recent Developments
7.12 Nordion, Inc.
7.12.1 Company Overview
7.12.2 Financial Overview
7.12.3 Business Strategies
7.12.4 Recent Developments
7.13 Qiagen GmbH
7.13.1 Company Overview
7.13.2 Financial Overview
7.13.3 Business Strategies
7.13.4 Recent Developments
Contact US:
Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
E: sales@marketresearchreports.biz
Blog: http://mresearchreports.blogspot.com/
This report covers the market analysis for various diagnostic tests performed to detect hospital associated infections, also called as nosocomial infections. Morbidity rate of nosocomial infections is increasing rapidly worldwide,thereby driving the hospital associated infection (HAI) diagnostic market towards remarkable growth. The stakeholders for this study include manufacturers and providers ofdiagnostic solutions for nosocomial infections.
The global hospital acquired disease testing market is categorized on the basis of infection types,i.e., urinary tract infection, surgical site infection, pneumonia,blood stream infection, MRSA infection and others. A detailed market analysis and forecast for these segments has been provided in this study, in terms of market revenue (USD million) for the period 2011 to 2019.The report also provides the compounded annual growth rate (CAGR %) for each infection type for the forecast period 2013 to 2019, while market size estimations have been made considering 2012 as the base year.
Browse Complete report with TOC : http://www.marketresearchreports.biz/analysis-details/hospital-acquired-disease-testing-market-pneumonia-uti-blood-stream-surgical-site-mrsa-infection-and-others-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
In terms of geographical distribution, the global hospital acquired disease testing market has been classified into four geographical areas, namely North America, Europe, Asia-Pacific and Rest of the World (RoW). The current and future market sizes (in terms of USD million) of the above regional markets have been provided in the report for the period 2011 to 2019 with their growth rate (%) for the period 2013 to 2019. The study further offers recommendations and highlights of the market, which would be useful for the current and future market players to sustain and grow in the global hospital acquired disease testing market.
The market overview section of the report demonstrates the market dynamics and market trends such as the drivers, restraints and opportunities that influence the current nature and future status of this field. Impact factors such as market attractiveness analysis and Porter’s five forces analysis have also been explained in the market overview section of the report, in order to give a thorough analysis of the overall competitive scenario in the global hospital acquired disease testing market.
This report concludes with the company profiles section which includes key information about the major players in this market. Some of the key players profiled in this report include Diatherix Laboratories Inc., Gen-Probe Inc., Qiagen GmbH, L Hoffman La Roche,Cepheid, Inc., Life Technologies Corporation, Meridian Biosciences, Cantel Medical Corporation, Nordion, Inc.and others.
To Download Sample Report Visit @ http://www.marketresearchreports.biz/sample/sample/185661
The global hospital acquired disease testing market is segmented as follows:
Hospital Acquired Disease TestingMarket, by Infection Type
• Pneumonia infection
• Urinary tract infection
• Blood stream associated infection
• Surgical site infection
• MRSA infection
• Others
Hospital Acquired Disease TestingMarket, by Geography
• North America
• Europe
• Asia-Pacific
• Rest of the World
Table of Content
Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 List of Abbreviations
Chapter 2 Executive Summary
Chapter 3 Market Overview
3.1 Overview – Current Market Scenario and Future Market Trends
3.1.1 Global Hospital Acquired Disease Testing Market Revenue, by Infection Type, 2011 – 2019 (USD Million)
3.2 Drivers
3.2.1 Establishment of Government Guidelines and Code of Prevention of HAIs
3.2.2 Increasing Prevalence of HAIs and Rise in the Number of Drug Resistant Pathogens
3.2.3 Expiration of Patents of Basic PCRs
3.3 Restraints
3.3.1 Lack of Budget and Skilled Labour in Developing Countries
3.3.2 Stringent Regulations and Guidance Framework
3.3.3 Lack of Controlling Authorities and Control Programmes in Less Developed Regions
3.4 Opportunities
3.4.1 Passing of the Patient Care and Affordable Care Act in the United States
3.4.2 Technological Developments in the Field of Molecular Diagnostics
3.5 Porter’s Five Force Analysis for the Global Hospital Acquired Disease Testing Market
3.5.1 Bargaining Power of Suppliers
3.5.2 Bargaining Power of Buyers
3.5.3 Threat of New Entrants
3.5.4 Threat of Substitutes
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis of Global Hospital Acquired Disease Testing Market, by Geography
Buy A copy Of This Report: http://www.marketresearchreports.biz/analysis/185661
Chapter 4 Global Hospital Acquired Disease Testing, by Infection Type
4.1 Overview – Current Market Scenario and Future Market Trends
4.1.1 Global Hospital Acquired Disease Testing Market, 2011 – 2019 (USD Million)
4.2 Urinary Tract Infection (UTI) Testing
4.2.1 Global Urinary Tract Infection Testing Market Revenue, 2011 – 2019 (USD Million)
4.3 Surgical Site Infection (SSI) Testing
4.3.1 Global Surgical Site Infection (SSI) Testing Market Revenue, 2011 - 2019 (USD Million)
4.4 Pneumonia Testing
4.4.1 Global Pneumonia Testing Market Revenue, 2011 - 2019 (USD Million)
4.5 Blood Stream Infection (BSI) Testing
4.5.1 Global Blood Stream Infection Testing Market Revenue, 2011 - 2019 (USD Million)
4.6 Methicillin-resistant Staphylococcus Aureus (MRSA) Testing
4.6.1 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Market Revenue, 2011 - 2019 (USD Million)
4.7 Others (GI, Bone, Respiratory, Cardiovascular, Etc.)
4.7.1 Global Other (GI, Joints, Respiratory, Cardiovascular, Etc.) Infections Testing Market Revenue, 2011 - 2019 (USD Million)
4.7.2 Respiratory Infections
4.7.3 Bone Infections
4.7.4 Cardiovascular Infections
4.7.5 Gastrointestinal Infections
Chapter 5 Global Hospital Acquired Disease Testing, by Geography
5.1 Overview – Current Market Scenario and Future Market Trends
5.1.1 Global Hospital Acquired Disease Testing Market Revenue, by Geography, 2011-2019 (USD Million)
5.2 North America
5.2.1 North America Hospital Acquired Disease Testing Market Revenue, 2011 - 2019 (USD Million)
5.2.2 North America Hospital Acquired Disease Testing Market Revenue, by Infection Type, 2011 – 2019 (USD Million)
5.3 Europe
5.3.1 Europe Hospital Acquired Disease Testing Market Revenue, 2011 – 2019 (USD Million)
5.3.2 Europe Hospital Acquired Disease Testing Market Revenue, by Infection Type, 2011 – 2019 (USD Million)
5.4 Asia-Pacific
5.4.1 Asia-Pacific Hospital Acquired Disease Testing Market Revenue, 2011 – 2019 (USD Million)
5.4.2 Asia-Pacific Hospital Acquired Disease Testing Market Revenue, by Infection Type, 2011 – 2019 (USD Million)
5.5 Rest of the World (RoW)
5.5.1 Rest of the World (RoW) Hospital Acquired Disease Testing Market Revenue, 2011 – 2019 (USD Million)
5.5.2 RoW Hospital Acquired Disease Testing Market Revenue, by Infection Type, 2011 – 2019 (USD Million)
Chapter 6 Recommendations
6.1 Educating and Training Hospital Staff
6.2 Focus on Expansion in Emerging Economies
6.3 Regulatory Compliance
6.4 Adapt to the Needs of Different Consumer Types
Chapter 7 Company Profiles
7.1 Abbott Laboratories, Inc.
7.1.1 Company Overview
7.1.2 Financial Overview
7.1.3 Business Strategies
7.1.4 Recent Developments
7.2 Alere, Inc.
7.2.1 Company Overview
7.2.2 Financial Overview
7.2.3 Business Strategies
7.2.4 Recent Developments
7.3 Becton, Dickinson and Company
7.3.1 Company Overview
7.3.2 Financial Overview
7.3.3 Business Strategies
7.3.4 Recent Developments
7.4 bioMerieux, Inc.
7.4.1 Company Overview
7.4.2 Financial Overview
7.4.3 Business Strategies
7.4.4 Recent Developments
7.5 Cantel Medical Corporation
7.5.1 Company Overview
7.5.2 Financial Overview
7.5.3 Business Strategies
7.5.4 Recent Developments
7.6 Cepheid, Inc.
7.6.1 Company Overview
7.6.2 Financial Overview
7.6.3 Business Strategies
7.7 Diatherix Laboratories Inc.
7.7.1 Company Overview
7.7.2 Business Strategies
7.7.3 Recent Developments
7.8 Gen-Probe, Inc.
7.8.1 Company Overview
7.8.2 Financial Overview
7.8.3 Business Strategies
7.8.4 Recent Developments
7.9 F. Hoffman-La Roche, Ltd.
7.9.1 Company Overview
7.9.2 Financial Overview
7.9.3 Business Strategies
7.9.4 Recent Developments
7.10 Life Technologies Corporation
7.10.1 Company Overview
7.10.2 Financial Overview
7.10.3 Business Strategies
7.10.4 Recent Developments
7.11 Meridian Bioscience, Inc.
7.11.1 Company Overview
7.11.2 Financial Overview
7.11.3 Business Strategies
7.11.4 Recent Developments
7.12 Nordion, Inc.
7.12.1 Company Overview
7.12.2 Financial Overview
7.12.3 Business Strategies
7.12.4 Recent Developments
7.13 Qiagen GmbH
7.13.1 Company Overview
7.13.2 Financial Overview
7.13.3 Business Strategies
7.13.4 Recent Developments
Contact US:
Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
E: sales@marketresearchreports.biz
Blog: http://mresearchreports.blogspot.com/
No comments:
Post a Comment